Brainstorm Cell Therapeutics shares owned by Raymond James & Associates
Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Raymond James & Associates
from 13F filings
Historical chart of Raymond James & Associates investment in Brainstorm Cell Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Brainstorm Cell Therapeutics held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Brainstorm Cell Therapeutics by Raymond James & Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $22k | 95k | 0.23 |
| 2024-06-30 | $38k | 111k | 0.34 |
| 2024-03-31 | $64k | 114k | 0.56 |
| 2023-12-31 | $32k | 116k | 0.27 |
| 2023-09-30 | $28k | 138k | 0.20 |
| 2023-06-30 | $339k | 165k | 2.06 |
| 2023-03-31 | $544k | 165k | 3.30 |
| 2022-12-31 | $349k | 213k | 1.64 |
| 2022-09-30 | $1.1M | 245k | 4.42 |
| 2022-06-30 | $517k | 187k | 2.76 |
| 2022-03-31 | $640k | 190k | 3.36 |
| 2021-12-31 | $758k | 190k | 4.00 |
| 2021-09-30 | $705k | 214k | 3.30 |
| 2021-06-30 | $759k | 200k | 3.80 |
| 2021-03-31 | $845k | 221k | 3.83 |
| 2020-12-31 | $1.6M | 347k | 4.52 |
| 2020-09-30 | $4.9M | 289k | 16.92 |
| 2020-06-30 | $2.8M | 254k | 11.21 |
| 2020-03-31 | $932k | 201k | 4.64 |
| 2019-12-31 | $520k | 122k | 4.28 |
| 2019-09-30 | $338k | 87k | 3.90 |
More positions owned by Raymond James & Associates
Home Depot (HD)
View all positions for Raymond James & Associates